Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
33.3%
% of MEDX's 32 holdings also in PJP
37.5%
% of PJP's 24 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.7% | 6.7% | 6.7% |
|
ABBVIE INC | 6.2% | 5.9% | 5.9% |
|
AMGEN INC | 5.2% | 6.4% | 5.2% |
|
JOHNSON & JOHNSON | 5.1% | 5.7% | 5.1% |
|
PFIZER INC | 4.6% | 5.2% | 4.6% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PJP
 |
NOVARTIS AG-ADR | 5.5% |
|
BRISTOL-MYERS SQUIBB CO | 5.1% |
|
ELI LILLY & CO | 5.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.7% |
|
CRISPR THERAPEUTICS AG | 4.4% |
|
IONIS PHARMACEUTICALS, INC. | 3.6% |
 |
SANOFI-AVENTIS-ADR | 3.4% |
 |
ALKERMES PLC | 3.3% |
|
ALNYLAM PHARMACEUTICALS INC | 2.7% |
|
EDITAS MEDICINE, INC. | 1.9% |
MEDX Underweight Relative to PJP
|
ABBOTT LABORATORIES | -6.1% |
|
AMPHASTAR PHARMACEUTICALS INC | -3.9% |
|
UNITED THERAPEUTICS CORP | -3.8% |
 |
TARO PHARMACEUTICAL INDUS | -3.8% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.7% |
|
LIGAND PHARMACEUTICALS-CL B | -3.4% |
|
JAZZ PHARMACEUTICALS PLC | -3.3% |
|
SUPERNUS PHARMACEUTICALS INC | -3.2% |
|
GERON CORP | -3.2% |
 |
VALEANT PHARMACEUTICALS INT'L | -3.1% |